United States · FDA National Drug Code directory
UZEDY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51759-630_fbc54ee2-4211-4765-a288-75778def0f5a
- Product NDC
- 51759-630
- Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- risperidone
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230501
- Source listing expiry
- 20271231
Source-listed ingredients
- RISPERIDONE — 125 mg/.35mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (51759-630-10) / .35 mL in 1 SYRINGE, GLASS · 51759-630-10
- 1 SYRINGE, GLASS in 1 CARTON (51759-630-11) / .35 mL in 1 SYRINGE, GLASS · 51759-630-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →